Dr. Faria Sana Amjad, MD

Dr. Amjad practices at Medstar Medical Group II in Arlington, Virginia.

Dr. Amjad's NPI, 1518285204, was assigned on May 5, 2010. Dr. Amjad graduated from Georgetown University School of Medicine in 2009. Dr. Amjad holds District of Columbia license MD041499.

Dr. Amjad's primary practice is Medstar Medical Group II, at 2000 15th N St, Arlington, VA 22201 in Arlington County. The practice phone is (443) 444-5606.

Dr. Amjad's primary practice is Medstar Medical Group II in Arlington, Virginia. Dr. Amjad is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Amjad to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amjad practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Amjad's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Amjad's licenses on file in 3 states: District of Columbia, Maryland and Virginia.

CMS data shows 476 Medicare services from Dr. Amjad across 7 procedure codes in 2024, for 167 Medicare patients. Medicare paid $54,011 for them. Every service was in an office.

CMS counts 167 Medicare patients who saw Dr. Amjad in 2024. The largest group is under 65, with 73 patients. 61% of them have high blood pressure, and 60% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amjad's median patient age at 53, with 70% women.

In 2024, Dr. Amjad wrote 1,086 Medicare Part D claims for 155 patients. 78% of them were for generic drugs. CMS names the drug for 828 of them, across 24 drugs with 11 or more claims each, at $1,722,837 in total drug cost. In 2023, CMS named 600 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Amjad for performance year 2024, reported as part of a group. Dr. Amjad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Amjad as offering telehealth.

Dmand AI links 6 papers to Dr. Amjad, published from 2015 to 2023. The most frequent topics are Magnetic Resonance Imaging. Dr. Amjad has published most often in Neurology. Dr. Amjad's most frequent co-authors are Carlo Salvator Tornatore, Sean Matthew Gratton, MD and Fahad Khan, MD.

CMS Open Payments shows 1,609 general payments to Dr. Amjad from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Biogen, Inc. paid the most, $258,412. It also lists 2 research payments totaling $1,515 in 2025.

Dr. Amjad graduated from Georgetown University School of Medicine in 2009.